Guru Ownership Trend
Guru Analysis for Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.08 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.41 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 24.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Allogene Therapeutics, Inc. (ALLO)
Major holders include Renaissance Technologies (RenTech) ($3 M), Cliff Asness ($1.96 M), Steven Cohen ($142,124). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.81 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.41 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited ALLO. The total reported sell value was $1.55 M.
Yes, 1 managers opened new positions in ALLO, and 0 increased their existing holdings. The total reported buy value was $142,124.